As previously reported, on September 26, 2023, Alzamend was notified by Nasdaq that it did not meet the minimum market value of listed securities requirement for continued listing on Nasdaq under ...

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...

Alzamend Neuro CEO Stephan Jackman to Participate in Maxim Group’s Virtual Healthcare Conference; Fireside Conversation on October 17th at 1:30 PM ET ...

Assassins need to deal quick damage, have mobility, and are great for skill expression. Lancelot, Gusion, Saber, Helcurt, ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections, today announced that it, Dr. Michael Newman ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

As is known, Russian fighters have the most far-sighted Irbis-E radar, detecting targets of the F—16V Block 70 type at a ...

Businessmen Simon Kelly and Jay Bourke are seeking €1 million from private investors through a State scheme to refit a ...

Umbral Eyes provide passive bonuses that grant additional effects to a variety of actions. These aren't necessarily limited to Umbral magic or the withered health mechanic, though many Umbral Eyes ...

Cellular immunity is a protective immune process that involves the activation of phagocytes, antigen-sensitized cytotoxic T cells and the release of cytokines and chemokines in response to antigen.

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...

NKG2D is a central activating receptor know to recognise stress ligangs upregulated during cancer or infection. Here, Charpak-Amikam et al show that NKG2D also recognises fungal pathogens and ...